← The Wire
LQDANasdaq
Liquidia Corp
Pharmaceutical Preparations · DE · CIK 1819576
Liquidia Corp develops and commercializes treatments for challenging respiratory and vascular diseases like pulmonary arterial hypertension
$6.33B
Market cap
$75.12
Last close
-3.9%
1D
-0.5%
5D
2.6M
Volume
Price · last 39 sessions+95.2%
May 4L $38.48 · H $78.17Jun 29
162
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 17, 20268-KCompany UpdateJun 8, 202610-Q10-QMay 11, 20268-KResults of Operations · Company UpdateMay 11, 2026DEFA14ADEFA14AApr 24, 2026DEF 14AFORM DEF 14AApr 24, 202610-K10-KMar 5, 20268-KResults of OperationsMar 5, 20268-KReg FD DisclosureJan 9, 202610-Q10-QNov 3, 20258-KResults of OperationsNov 3, 20258-KMaterial AgreementOct 30, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KExecutive ChangeJul 1, 20258-KCompany UpdateJun 24, 20258-KShareholder VoteJun 18, 20258-KMaterial AgreementJun 18, 20258-KCompany UpdateJun 2, 20258-KCompany UpdateMay 23, 20258-KCompany UpdateMay 12, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KCompany UpdateMay 8, 20258-KCompany UpdateMay 5, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KCompany UpdateApr 22, 20258-KCompany UpdateMar 28, 202510-K10-KMar 19, 20258-KResults of OperationsMar 19, 20258-KMaterial Agreement · Company UpdateMar 18, 20258-KCompany UpdateFeb 28, 20258-KMaterial AgreementNov 26, 202410-Q10-QNov 13, 20248-KResults of OperationsNov 13, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GOct 18, 20248-KCompany UpdateOct 7, 20248-KMaterial Agreement · Company UpdateOct 2, 20248-KCompany UpdateSep 17, 20248-KEquity Issuance · Company UpdateSep 12, 2024424B4424B4Sep 11, 20248-KMaterial Agreement · Company UpdateSep 11, 20248-KMaterial AgreementSep 11, 20248-KCompany UpdateAug 22, 20248-KCompany UpdateAug 19, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KShareholder VoteJun 21, 20248-KCompany UpdateJun 3, 20248-KCompany UpdateMay 31, 20248-KExecutive ChangeMay 14, 20248-KResults of OperationsMay 14, 202410-Q10-QMay 13, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 20248-KCompany UpdateApr 1, 202410-K10-KMar 13, 20248-KResults of OperationsMar 13, 2024SC 13GSC 13GJan 31, 20248-KCompany UpdateJan 25, 20248-KCompany UpdateJan 23, 20248-KExecutive Change · Company UpdateJan 19, 2024SC 13GSC 13GJan 16, 20248-KEquity Issuance · Company UpdateJan 8, 20248-KMaterial Agreement · Company UpdateJan 5, 20248-KCompany UpdateDec 20, 20238-KEquity Issuance · Company UpdateDec 14, 20238-KMaterial Agreement · Company UpdateDec 12, 20238-KCompany UpdateDec 12, 20238-KReg FD DisclosureDec 1, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KCompany UpdateSep 25, 20238-KCompany UpdateSep 6, 20238-KReg FD DisclosureAug 21, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KMaterial Agreement · Company UpdateJul 27, 2023
Insider Activity
In the 90 days to Mar 27, 2026: 10 sold $16.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | Bloch Stephen MDirector | Sell | 30,176 | $36.38 | $1.1M |
| Mar 27, 2026 | Bloch Stephen MDirector | Sell | 30,401 | $35.42 | $1.1M |
| Mar 27, 2026 | Bloch Stephen MDirector | Sell | 1,973 | $37.13 | $73K |
| Mar 26, 2026 | Bloch Stephen MDirector | Sell | 7,684 | $37.22 | $286K |
| Mar 23, 2026 | Moomaw ScottChief Commercial Officer | Sell | 17,000 | $36.81 | $626K |
| Mar 23, 2026 | Moomaw ScottChief Commercial Officer | Sell | 1,314 | $36.48 | $48K |
| Mar 13, 2026 | Saggar RajeevChief Medical Officer | Sell | 35,365 | $36.30 | $1.3M |
| Mar 13, 2026 | Singh RamanDirector | Sell | 20,000 | $36.04 | $721K |
| Mar 13, 2026 | Krepp SarahChief Human Resource Officer | Sell | 16,261 | $38.00 | $618K |
| Mar 9, 2026 | Moomaw ScottChief Commercial Officer | Sell | 80,000 | $35.32 | $2.8M |
| Mar 2, 2026 | Kaseta MichaelCFO and COO | Sell | 1,165 | $30.58 | $36K |
| Mar 2, 2026 | Schundler RussellGeneral Counsel | Sell | 1,073 | $30.58 | $33K |
| Mar 2, 2026 | Moomaw ScottChief Commercial Officer | Sell | 827 | $30.58 | $25K |
| Mar 2, 2026 | Adair JasonChief Business Officer | Sell | 689 | $30.58 | $21K |
| Mar 2, 2026 | Boyle DanaChief Accounting Officer | Sell | 445 | $30.58 | $14K |
| Mar 2, 2026 | Krepp SarahChief Human Resource Officer | Sell | 276 | $30.58 | $8K |
| Jan 26, 2026 | Boyle DanaChief Accounting Officer | Sell | 1,580 | $41.65 | $66K |
| Jan 26, 2026 | Adair JasonChief Business Officer | Sell | 688 | $41.65 | $29K |
| Jan 12, 2026 | Jeffs RogerChief Executive Officer | Sell | 66,610 | $37.43 | $2.5M |
| Jan 12, 2026 | Kaseta MichaelCFO and COO | Sell | 36,932 | $37.43 | $1.4M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance